← Leaderboards
Jason Knight
University Of Michigan At Ann Arbor
$7,353,823
Attributed
$7,353,823
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,353,823 · 4
By mechanism
R01$4,475,558 · 1
T32$1,757,460 · 1
K08$691,805 · 1
R21$429,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Suzanna M Zick$3,669,839
- Deborah L. Gumucio$17,750,962
- Andrea Tara Obi$2,571,508
- Yu Zuo$692,543
- Arturo Diaz$380,700
Others in their field
Top investigators on “Extracellular”
- Marinella Temprosa · George Washington University$48,628,632
- Prescott G Woodruff · University Of California San Francisco$30,601,186
- Ed Lein · Allen Institute$26,451,910
- Naftali Kaminski · Yale University$23,053,857
- Richard L Huganir · Johns Hopkins University$21,712,765
- Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
Research focus
ExtracellularThrombosisSignal TransductionChromatinNeutrophilMediatingBlood VesselsEventAntiphospholipid AntibodiesNeutrophil ActivationInflammationLupusBlood CoagulationBlood PlateletsIn VitroTrainingAutoimmune DiseasesVenous ThrombosisRheumatologyEndothelial CellsNeurofibrillary TanglesPurinergic P1 ReceptorsSignal PathwayAgonist
Grant awards (24)
Purinergic modulation of the autoimmune vascular phenotype$369,734
R01 · FY2025 · HL · contact PI
Scientist Training in Rheumatology Research$181,684
T32 · FY2025 · AR · contact PI
Purinergic modulation of the autoimmune vascular phenotype$396,640
R01 · FY2024 · HL · contact PI
Scientist Training in Rheumatology Research$366,092
T32 · FY2024 · AR · contact PI
Scientist Training in Rheumatology Research$86,976
T32 · FY2024 · AR · contact PI
NETs as therapeutic targets in obstetric APS$429,000
R21 · FY2023 · HD · contact PI
Purinergic modulation of the autoimmune vascular phenotype$361,154
R01 · FY2023 · HL · contact PI
Scientist Training in Rheumatology Research$353,432
T32 · FY2023 · AR · contact PI
Scientist Training in Rheumatology Research$169,430
T32 · FY2023 · AR · contact PI
Purinergic modulation of the autoimmune vascular phenotype$567,640
R01 · FY2022 · HL · contact PI
Training of Arthritis Research Scientists$303,116
T32 · FY2022 · AR · contact PI
Purinergic modulation of the autoimmune vascular phenotype$567,640
R01 · FY2021 · HL · contact PI
Training of Arthritis Research Scientists$296,730
T32 · FY2021 · AR · contact PI
Purinergic modulation of the autoimmune vascular phenotype$553,903
R01 · FY2020 · HL · contact PI
Purinergic modulation of the autoimmune vascular phenotype$390,000
R01 · FY2020 · HL · contact PI
Purinergic modulation of the autoimmune vascular phenotype$156,000
R01 · FY2020 · HL · contact PI
Purinergic modulation of the autoimmune vascular phenotype$578,283
R01 · FY2019 · HL · contact PI
Purinergic modulation of the autoimmune vascular phenotype$534,564
R01 · FY2018 · HL · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$96,753
K08 · FY2018 · AR · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$168,674
K08 · FY2017 · AR · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$864
K08 · FY2017 · AR · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$168,594
K08 · FY2016 · AR · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$128,520
K08 · FY2015 · AR · contact PI
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy$128,400
K08 · FY2014 · AR · contact PI